Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads.

The first targeted inhibitors of an essential M. tuberculosis cell wall lipase, Rv3802c, are described. Lead compounds exhibited nanomolar inhibition of the enzyme, and encouraging antibacterial activity against M.